Lichen sclerosus and the risk of malignant progression: a case series of 159 patients

G Ital Dermatol Venereol. 2013 Dec;148(6):673-8.

Abstract

Aim and methods: We analyzed 159 stored specimens of Lichen Sclerosus (LS) collected in the period 1999-2011 from 159 patients, in order to evaluate the histological patterns, clinical outcomes and possible associations with malignancies. The histopathologic analysis revealed 145 cases (males and females) with LS alone, 7 in whom penile LS was associated with spinocellular carcinoma (SCC), and 7 in whom LS was associated with a pseudocarcinomatous-hyperplasia (PCH). Extragenital LS was found in 20% (17/85) of the males and 78% (58/74) of the females. In the cases of SCC, immunohistochemical analyses was performed.

Results and conclusion: The results showed very low positivity to p16INK4A and Ki-67; biomolecular PCR was positive in only two cases, and in both cases the non-oncogenic genotype HPV 100 was detected. No important additional risk factors for malignancies were found (e.g., hormones, infections, other autoimmune diseases).

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / surgery
  • Cell Transformation, Neoplastic*
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis
  • Disease Progression
  • Female
  • Genotype
  • Humans
  • Ki-67 Antigen / analysis
  • Lichen Sclerosus et Atrophicus / complications
  • Lichen Sclerosus et Atrophicus / pathology*
  • Male
  • Middle Aged
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / pathology*
  • Papillomavirus Infections / virology
  • Penile Neoplasms / chemistry
  • Penile Neoplasms / complications
  • Penile Neoplasms / pathology*
  • Penile Neoplasms / surgery
  • Polymerase Chain Reaction
  • Risk Factors
  • Skin Neoplasms / chemistry
  • Skin Neoplasms / complications
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery

Substances

  • Biomarkers, Tumor
  • Cyclin-Dependent Kinase Inhibitor p16
  • Ki-67 Antigen